KA
JAZZ icon

Kovack Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Kovack Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$220K Sell
921
-183
-17% -$40.1K 0.01% 959
2026
Q1 		$208K Sell
1,104
-52,381
-98% -$9.15M 0.01% 915
2025
Q4 		$9.09M Sell
53,485
-748
-1% -$115K 0.42% 44
2025
Q3 		$7.15M Sell
54,233
-2,252
-4% -$270K 0.67% 32
2025
Q2 		$5.99M Buy
56,485
+2,068
+4% +$225K 0.59% 35
2025
Q1 		$6.76M Sell
54,417
-449
-0.8% -$58.6K 0.72% 26
2024
Q4 		$6.76M Sell
54,866
-2,806
-5% -$331K 0.66% 30
2024
Q3 		$6.43M Buy
57,672
+9,783
+20% +$1.07M 0.68% 28
2024
Q2 		$5.11M Sell
47,889
-8,710
-15% -$958K 0.56% 32
2024
Q1 		$6.82M Buy
56,599
+26,628
+89% +$3.26M 0.83% 16
2023
Q4 		$3.69M Buy
29,971
+23,267
+347% +$2.9M 0.44% 37
2023
Q3 		$868K Buy
6,704
+2,453
+58% +$327K 0.12% 158
2023
Q2 		$527K Buy
+4,251
New +$572K 0.07% 283
2015
Q3 		– Sell
-1,556
Closed -$274K – 232
2015
Q2 		$274K Buy
+1,556
New +$279K 0.19% 141
2015
Q1 		– Sell
-1,314
Closed -$215K – 203
2014
Q4 		$215K Buy
+1,314
New +$218K 0.22% 122

Other funds holding JAZZ

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Kovack Advisors's JAZZ Position: Q2 2026 in Review

Kovack Advisors reduced its Jazz Pharmaceuticals (JAZZ) stake by 17% in Q2 2026, selling an estimated $40.1K and leaving 921 shares worth $220K. The position accounts for 0.01% of the portfolio, ranked #959.

Kovack Advisors first reported a position in JAZZ in Q4 2014 and has held it in 15 quarters since. The position peaked at $9.09M in Q4 2025. 177 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Kovack Advisors held 921 shares of Jazz Pharmaceuticals worth $220K as of Q2 2026.
  • Kovack Advisors sold 183 Jazz Pharmaceuticals shares in Q2 2026, an estimated $40.1K.
  • Jazz Pharmaceuticals made up 0.01% of Kovack Advisors's portfolio in Q2 2026, its #959 holding.
  • Kovack Advisors first reported a position in Jazz Pharmaceuticals in Q4 2014 and has held it in 15 quarters since.
  • Kovack Advisors's Jazz Pharmaceuticals position peaked at $9.09M in Q4 2025.
  • 177 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Kovack Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.